Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309


Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections?

Carpenter AF, Goodwin SJ, Bornstein PF, Larson AJ, Markus CK.

Mult Scler. 2017 Feb;23(2):297-299. doi: 10.1177/1352458516670732.


Bioactive nanofibers enable the identification of thrombospondin 2 as a key player in enamel regeneration.

Huang Z, Newcomb CJ, Lei Y, Zhou Y, Bornstein P, Amendt BA, Stupp SI, Snead ML.

Biomaterials. 2015 Aug;61:216-28. doi: 10.1016/j.biomaterials.2015.05.035. Epub 2015 May 19.


Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts.

Reinecke H, Robey TE, Mignone JL, Muskheli V, Bornstein P, Murry CE.

Cardiovasc Pathol. 2013 Jan-Feb;22(1):91-5. doi: 10.1016/j.carpath.2012.03.005. Epub 2012 Apr 16.


Dynamic reciprocity in the wound microenvironment.

Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM.

Wound Repair Regen. 2011 Mar-Apr;19(2):134-48. doi: 10.1111/j.1524-475X.2011.00673.x. Review.


Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing.

Ono K, Wang X, Kim SO, Armstrong LC, Bornstein P, Han J.

Protein Cell. 2010 Feb;1(2):161-73. doi: 10.1007/s13238-010-0017-y. Erratum in: Protein Cell. 2010 Dec;1(12):1128.


Thrombospondin-4 regulates vascular inflammation and atherogenesis.

Frolova EG, Pluskota E, Krukovets I, Burke T, Drumm C, Smith JD, Blech L, Febbraio M, Bornstein P, Plow EF, Stenina OI.

Circ Res. 2010 Nov 26;107(11):1313-25. doi: 10.1161/CIRCRESAHA.110.232371. Epub 2010 Sep 30.


Expression in SPARC-null mice of collagen type I lacking the globular domain of the α1(I) N-propeptide results in abdominal hernias and loss of dermal collagen.

Card L, Henderson N, Zhang Y, Bornstein P, Bradshaw AD.

Matrix Biol. 2010 Sep;29(7):559-64. doi: 10.1016/j.matbio.2010.08.002. Epub 2010 Aug 11.


Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.

Swinnen M, Vanhoutte D, Van Almen GC, Hamdani N, Schellings MW, D'hooge J, Van der Velden J, Weaver MS, Sage EH, Bornstein P, Verheyen FK, VandenDriessche T, Chuah MK, Westermann D, Paulus WJ, Van de Werf F, Schroen B, Carmeliet P, Pinto YM, Heymans S.

Circulation. 2009 Oct 20;120(16):1585-97. doi: 10.1161/CIRCULATIONAHA.109.863266. Epub 2009 Oct 5.


Thrombospondins function as regulators of angiogenesis.

Bornstein P.

J Cell Commun Signal. 2009 Dec;3(3-4):189-200. doi: 10.1007/s12079-009-0060-8. Epub 2009 Oct 2.


Matricellular proteins: an overview.

Bornstein P.

J Cell Commun Signal. 2009 Dec;3(3-4):163-5. doi: 10.1007/s12079-009-0069-z. Epub 2009 Sep 25. No abstract available.


Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis.

Kyriakides TR, Wulsin D, Skokos EA, Fleckman P, Pirrone A, Shipley JM, Senior RM, Bornstein P.

Matrix Biol. 2009 Mar;28(2):65-73. doi: 10.1016/j.matbio.2009.01.001. Epub 2009 Jan 20.


Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.

Sun J, Hopkins BD, Tsujikawa K, Perruzzi C, Adini I, Swerlick R, Bornstein P, Lawler J, Benjamin LE.

Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1344-51. doi: 10.1152/ajpheart.01246.2008. Epub 2009 Mar 20.


Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9.

MacLauchlan S, Skokos EA, Meznarich N, Zhu DH, Raoof S, Shipley JM, Senior RM, Bornstein P, Kyriakides TR.

J Leukoc Biol. 2009 Apr;85(4):617-26. doi: 10.1189/jlb.1008588. Epub 2009 Jan 13.


Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF.

Maclauchlan S, Skokos EA, Agah A, Zeng J, Tian W, Davidson JM, Bornstein P, Kyriakides TR.

J Histochem Cytochem. 2009 Apr;57(4):301-13. doi: 10.1369/jhc.2008.952689. Epub 2008 Nov 24.


Disruption of the thrombospondin-2 gene alters the lamellar morphology but does not permit vascularization of the adult mouse lumbar disc.

Gruber HE, Bornstein P, Sage EH, Ingram JA, Zinchenko N, Norton HJ, Hanley EN Jr.

Arthritis Res Ther. 2008;10(4):R96. doi: 10.1186/ar2483. Epub 2008 Aug 21.


Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis.

Krady MM, Zeng J, Yu J, MacLauchlan S, Skokos EA, Tian W, Bornstein P, Sessa WC, Kyriakides TR.

Am J Pathol. 2008 Sep;173(3):879-91. doi: 10.2353/ajpath.2008.080128. Epub 2008 Aug 7.


Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen.

Posey KL, Hankenson K, Veerisetty AC, Bornstein P, Lawler J, Hecht JT.

Am J Pathol. 2008 Jun;172(6):1664-74. doi: 10.2353/ajpath.2008.071094. Epub 2008 May 8.


Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells.

Oganesian A, Armstrong LC, Migliorini MM, Strickland DK, Bornstein P.

Mol Biol Cell. 2008 Feb;19(2):563-71. Epub 2007 Nov 21.


SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts.

Rentz TJ, Poobalarahi F, Bornstein P, Sage EH, Bradshaw AD.

J Biol Chem. 2007 Jul 27;282(30):22062-71. Epub 2007 May 23.


Interactions between CD47 and thrombospondin reduce inflammation.

Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A.

J Immunol. 2007 May 1;178(9):5930-9.


Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice.

Daniel C, Amann K, Hohenstein B, Bornstein P, Hugo C.

J Am Soc Nephrol. 2007 Mar;18(3):788-98. Epub 2007 Feb 7.


Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells.

Raman P, Krukovets I, Marinic TE, Bornstein P, Stenina OI.

J Biol Chem. 2007 Feb 23;282(8):5704-14. Epub 2006 Dec 18.


Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.

Kopp HG, Hooper AT, Broekman MJ, Avecilla ST, Petit I, Luo M, Milde T, Ramos CA, Zhang F, Kopp T, Bornstein P, Jin DK, Marcus AJ, Rafii S.

J Clin Invest. 2006 Dec;116(12):3277-91.


TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax.

Bellot G, Cartron PF, Er E, Oliver L, Juin P, Armstrong LC, Bornstein P, Mihara K, Manon S, Vallette FM.

Cell Death Differ. 2007 Apr;14(4):785-94. Epub 2006 Nov 10.


The NH2-terminal propeptide of type I procollagen acts intracellularly to modulate cell function.

Oganesian A, Au S, Horst JA, Holzhausen LC, Macy AJ, Pace JM, Bornstein P.

J Biol Chem. 2006 Dec 15;281(50):38507-18. Epub 2006 Oct 3.


Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1.

Nishiwaki T, Yamaguchi T, Zhao C, Amano H, Hankenson KD, Bornstein P, Toyama Y, Matsuo K.

J Bone Miner Res. 2006 Apr;21(4):596-604. Epub 2006 Apr 5.


Mice with a deletion in the first intron of the Col1a1 gene develop dissection and rupture of aorta in the absence of aneurysms: high-resolution magnetic resonance imaging, at 4.7 T, of the aorta and cerebral arteries.

Marjamaa J, Tulamo R, Abo-Ramadan U, Hakovirta H, Frösen J, Rahkonen O, Niemelä M, Bornstein P, Penttinen R, Kangasniemi M.

Magn Reson Med. 2006 Mar;55(3):592-7.


Mice lacking thrombospondin 2 show an atypical pattern of endocortical and periosteal bone formation in response to mechanical loading.

Hankenson KD, Ausk BJ, Bain SD, Bornstein P, Gross TS, Srinivasan S.

Bone. 2006 Mar;38(3):310-6. Epub 2005 Nov 14.


Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model.

Fears CY, Grammer JR, Stewart JE Jr, Annis DS, Mosher DF, Bornstein P, Gladson CL.

Cancer Res. 2005 Oct 15;65(20):9338-46.


Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo.

Chen J, Somanath PR, Razorenova O, Chen WS, Hay N, Bornstein P, Byzova TV.

Nat Med. 2005 Nov;11(11):1188-96. Epub 2005 Oct 16.


Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.

Kalas W, Yu JL, Milsom C, Rosenfeld J, Benezra R, Bornstein P, Rak J.

Cancer Res. 2005 Oct 1;65(19):8878-86.


Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice.

Hankenson KD, James IE, Apone S, Stroup GB, Blake SM, Liang X, Lark MW, Bornstein P.

Matrix Biol. 2005 Aug;24(5):362-70.


SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.

Puolakkainen PA, Bradshaw AD, Brekken RA, Reed MJ, Kyriakides T, Funk SE, Gooden MD, Vernon RB, Wight TN, Bornstein P, Sage EH.

J Histochem Cytochem. 2005 May;53(5):571-81.


Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis.

Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA.

Cell. 2005 Feb 11;120(3):421-33.


The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation.

Kyriakides TR, Foster MJ, Keeney GE, Tsai A, Giachelli CM, Clark-Lewis I, Rollins BJ, Bornstein P.

Am J Pathol. 2004 Dec;165(6):2157-66.


Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.

Schroen B, Heymans S, Sharma U, Blankesteijn WM, Pokharel S, Cleutjens JP, Porter JG, Evelo CT, Duisters R, van Leeuwen RE, Janssen BJ, Debets JJ, Smits JF, Daemen MJ, Crijns HJ, Bornstein P, Pinto YM.

Circ Res. 2004 Sep 3;95(5):515-22. Epub 2004 Jul 29.


The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury.

Bornstein P, Agah A, Kyriakides TR.

Int J Biochem Cell Biol. 2004 Jun;36(6):1115-25. Review. Erratum in: Int J Biochem Cell Biol. 2005 Jan;37(1):239-40.


Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.

Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, Streilein JW.

Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1117-24.


Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis.

Agah A, Kyriakides TR, Letrondo N, Björkblom B, Bornstein P.

Matrix Biol. 2004 Jan;22(7):539-47.


Matricellular proteins as modulators of wound healing and the foreign body response.

Kyriakides TR, Bornstein P.

Thromb Haemost. 2003 Dec;90(6):986-92. Review.


Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture.

Rahkonen O, Su M, Hakovirta H, Koskivirta I, Hormuzdi SG, Vuorio E, Bornstein P, Penttinen R.

Circ Res. 2004 Jan 9;94(1):83-90. Epub 2003 Nov 20.


Covalent cross-links in collagen: a personal account of their discovery.

Bornstein P.

Matrix Biol. 2003 Sep;22(5):385-91. No abstract available.


Thrombospondin 2 deficiency in pregnant mice results in premature softening of the uterine cervix.

Kokenyesi R, Armstrong LC, Agah A, Artal R, Bornstein P.

Biol Reprod. 2004 Feb;70(2):385-90. Epub 2003 Oct 15.


Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline.

Kalas W, Gilpin S, Yu JL, May L, Krchnakova H, Bornstein P, Rak J.

Biochem Biophys Res Commun. 2003 Oct 10;310(1):109-14.


Megakaryocytes require thrombospondin-2 for normal platelet formation and function.

Kyriakides TR, Rojnuckarin P, Reidy MA, Hankenson KD, Papayannopoulou T, Kaushansky K, Bornstein P.

Blood. 2003 May 15;101(10):3915-23.


Thrombospondins 1 and 2 function as inhibitors of angiogenesis.

Armstrong LC, Bornstein P.

Matrix Biol. 2003 Mar;22(1):63-71. Review.


Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials.

Puolakkainen P, Bradshaw AD, Kyriakides TR, Reed M, Brekken R, Wight T, Bornstein P, Ratner B, Sage EH.

Am J Pathol. 2003 Feb;162(2):627-35.

Supplemental Content

Loading ...
Support Center